Skip to content

Evaluation of parboiled rice in Glycemic Management of Hospitalized Patients with Type 2 Diabetes: A Randomized Crossover Study

Evaluation of parboiled rice in Glycemic Management of Hospitalized Patients with Type 2 Diabetes: A Randomized Crossover Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500110696
Enrollment
Unknown
Registered
2025-10-17
Start date
2025-05-14
Completion date
Unknown
Last updated
2025-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes Mellitus, T2DM

Interventions

Group 1:Day 1-Parboiled Rice Intervention ? Day 2- Regular White Rice Intervention
Group 2:Day 1-Regular White Rice Intervention ? Day 2- Parboiled Rice Intervention

Sponsors

The Second Affiliated Hospital of Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Hospitalized patients with type 2 diabetes aged between 18 and 75 years; 2.Duration of diabetes less than 10 years; 3.No severe cardiac, hepatic, renal complications, or other serious chronic diseases.

Exclusion criteria

Exclusion criteria: 1.Patients with type 1 diabetes; 2.Pregnant or lactating women; 3.Patients with malignancies; 4.Patients with diabetic ketoacidosis or hyperosmolar hyperglycemic syndrome; 5.Patients allergic to parboiled rice; 6.Patients who are fasting or unable to eat independently.

Design outcomes

Primary

MeasureTime frame
Improvement in glycemic control (e.g., preprandial and postprandial blood glucose, fasting blood glucose, 2-hour postprandial blood glucose, etc.);

Secondary

MeasureTime frame
Continuous glucose monitoring indicators;Improvement in other stress, inflammatory, and islet function indicators (e.g., CRP, C-peptide, insulin, etc.);

Countries

China

Contacts

Public ContactWangen Li

The Second Affiliated Hospital of Guangzhou Medical University

liwg660@126.com+86 20 3415 2032

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026